EUVIMEDEUVIMED entdecken
Crossref

Identification of potential methyltransferase NSD2 enzymatic inhibitors through a multi-step structure-based drug design

Yunpeng Shen, Yingying Zhang, Tongyi Wu, Lixue Zhang, Benny Danilo Belviso

Molecular Diversity · 2025

DOI: 10.1007/s11030-024-11072-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Yunpeng Shen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Biological Engineering, Henan University of Technology, Henan Province, Zhengzhou, 450001, People's Republic o…. Hauptthemen laut MEDLINE: Histone-Lysine N-Methyltransferase, Drug Design, Enzyme Inhibitors, Repressor Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: The Undergraduate Education Teaching Reform Research and Practice Program, The Basic Research Program of Key Science and Technology Research Projects in Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reversing aberrant protein methylation levels is widely recognized as a key focus in cancer therapy. As an essential lysine methylation regulator, NSD2 (Nuclear receptor-binding SET Domain 2, also known as WHSC1/MMSET) regulates chromatin structural sparsity and DNA repair processes. Abnormal enhancement of NSD2 methylation activity (caused by NSD2 overexpression and point mutations) has been closely related to the initiation and development of various cancers and diseases. However, the lack of selective inhibitors hinders further therapeutic intervention and limits the exploration of its biological mechanism. Therefore, this study developed an integrated approach that includes binding feature pharmacophore modeling, gradient database screening of 120 million compounds, flexible docking, and molecular dynamic simulation. This approach was used to identify hit compounds targeting the substrate/coenzyme binding site of NSD2. Subsequently, 20 lead compounds were retrieved by using molecular docking analysis and ADMET prediction. Finally, MD simulations were performed to validate the binding stability of selected drug candidates. The findings indicated that these newly obtained compounds might be potent NSD2 inhibitors. We hope the integrated virtual screening approach will provide a valuable idea for discovering novel H3K36 methyltransferase inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone-Lysine N-MethyltransferaseDrug DesignEnzyme InhibitorsRepressor ProteinsMolecular Docking SimulationMolecular Dynamics SimulationHumansBinding SitesProtein Binding

Stichwörter der Autor:innen

Epigenetic therapyInhibitorsMethylationNSD2Pharmacophore modelingVirtual screening

Substanzen

Histone-Lysine N-MethyltransferaseEnzyme InhibitorsNSD2 protein, humanRepressor Proteins

Autor:innen und Institutionen

  • Department of Biotechnology, School of Biological Engineering, Henan University of Technology, Henan Province, Zhengzhou, 450001, People's Republic of China. shenswjs@haut.edu.cn.
  • Department of Biotechnology, School of Biological Engineering, Henan University of Technology, Henan Province, Zhengzhou, 450001, People's Republic of China.
  • Department of Biotechnology, School of International Education, Henan University of Technology, Henan Province, Zhengzhou, 450001, People's Republic of China.
  • Institute of Crystallography, Consiglio Nazionale Delle Ricerche (CNR), 70126, Bari, Italy.

Förderung

  • The Undergraduate Education Teaching Reform Research and Practice Program
  • The Basic Research Program of Key Science and Technology Research Projects in Henan Province

Zitieren

APA

Shen, Y., Zhang, Y., Wu, T., Zhang, L., & Belviso, B. D. (2025). Identification of potential methyltransferase NSD2 enzymatic inhibitors through a multi-step structure-based drug design. Molecular Diversity. https://doi.org/10.1007/s11030-024-11072-8

Vancouver

Shen Y, Zhang Y, Wu T, Zhang L, Belviso BD. Identification of potential methyltransferase NSD2 enzymatic inhibitors through a multi-step structure-based drug design. Molecular Diversity. 2025. doi:10.1007/s11030-024-11072-8

BibTeX
@article{Shen2025,
  author = {Shen, Yunpeng and Zhang, Yingying and Wu, Tongyi and Zhang, Lixue and Belviso, Benny Danilo},
  title = {Identification of potential methyltransferase NSD2 enzymatic inhibitors through a multi-step structure-based drug design},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-024-11072-8}
}
Kostenlos starten →